Suppr超能文献

一项关于急性脑缺血患者吸入分子氢(H2)的基础研究,用于通过生理参数进行安全性检查并测量血液中H2水平。

A basic study on molecular hydrogen (H2) inhalation in acute cerebral ischemia patients for safety check with physiological parameters and measurement of blood H2 level.

作者信息

Ono Hirohisa, Nishijima Yoji, Adachi Naoto, Sakamoto Masaki, Kudo Yohei, Kaneko Kumi, Nakao Atsunori, Imaoka Takashi

机构信息

Department of Neurosurgery, Nishijima Hospital, Oooka, Numazu City, Sizuoka, Japan.

Department of Surgery, University of Pittsburgh, Pittsburgh, USA.

出版信息

Med Gas Res. 2012 Aug 23;2(1):21. doi: 10.1186/2045-9912-2-21.

Abstract

BACKGROUND

In animal experiments, use of molecular hydrogen ( H2) has been regarded as quite safe and effective, showing benefits in multiple pathological conditions such as ischemia-reperfusion injury of the brain, heart, kidney and transplanted tissues, traumatic and surgical injury of the brain and spinal cord, inflammation of intestine and lung , degenerative striatonigral tissue and also in many other situations. However, since cerebral ischemia patients are in old age group, the safety information needs to be confirmed. For the feasibility of H2 treatment in these patients, delivery of H2 by inhalation method needs to be checked for consistency.

METHODS

Hydrogen concentration (HC) in the arterial and venous blood was measured by gas chromatography on 3 patients, before, during and after 4% (case 1) and 3% (case2,3) H2 gas inhalation with simultaneous monitoring of physiological parameters. For a consistency study, HC in the venous blood of 10 patients were obtained on multiple occasions at the end of 30-min H2 inhalation treatment.

RESULTS

The HC gradually reached a plateau level in 20 min after H2 inhalation in the blood, which was equivalent to the level reported by animal experiments. The HC rapidly decreased to 10% of the plateau level in about 6 min and 18 min in arterial and venous blood, respectively after H2 inhalation was discontinued. Physiological parameters on these 3 patients were essentially unchanged by use of hydrogen. The consistency study of 10 patients showed the HC at the end of 30-min inhalation treatment was quite variable but the inconsistency improved with more attention and encouragement.

CONCLUSION

H2 inhalation of at least 3% concentration for 30 min delivered enough HC, equivalent to the animal experiment levels, in the blood without compromising the safety. However, the consistency of H2 delivery by inhalation needs to be improved.

摘要

背景

在动物实验中,分子氢(H₂)的使用被认为相当安全有效,在多种病理状况下都显示出益处,如脑、心脏、肾脏及移植组织的缺血再灌注损伤,脑和脊髓的创伤及手术损伤,肠道和肺部炎症,纹状体黑质组织退变,以及许多其他情况。然而,由于脑缺血患者多为老年群体,其安全性信息需要得到确认。对于H₂治疗在这些患者中的可行性,需检查通过吸入法输送H₂的一致性。

方法

对3例患者在吸入4%(病例1)和3%(病例2、3)H₂气体之前、期间及之后,通过气相色谱法测量动脉血和静脉血中的氢浓度(HC),同时监测生理参数。为进行一致性研究,在30分钟H₂吸入治疗结束时,多次获取10例患者静脉血中的HC。

结果

H₂吸入后,血液中的HC在20分钟内逐渐达到平台水平,这与动物实验报告的水平相当。停止H₂吸入后,动脉血和静脉血中的HC分别在约6分钟和18分钟内迅速降至平台水平的10%。这3例患者的生理参数因使用氢气基本未发生变化。10例患者的一致性研究表明,30分钟吸入治疗结束时的HC变化很大,但通过更多关注和鼓励,不一致性有所改善。

结论

吸入至少3%浓度的H₂ 30分钟可在血液中输送足够的HC,相当于动物实验水平,且不影响安全性。然而,通过吸入输送H₂的一致性需要改进。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e04d/3457852/fcad93530cba/2045-9912-2-21-1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验